OBJECTIVE: To explore age and gender differences in the impact of diabetes on the prevalence of ischemic heart disease (IHD) in a defined population. METHODS: Data were obtained from an administrative health care register covering a population of about 415,000. The study included all patients aged 45-74 years diagnosed between 1999 and 2003 with IHD (n=11,311) and diabetes (n=10,364) by physicians at all primary health care centres (PHCs) and out- and inpatient clinics at all hospitals in the county of Ostergötland, Sweden. RESULTS: In the 45-54-year-old age group, diabetes was associated with an increase in IHD prevalence equivalent to ageing about 20 years in women and 10 years in men. The diabetes/nondiabetes IHD prevalence rate ratio (IPR) decreased with age in both men and women (trend p-values <0.001). The IPR was higher among women than men in each age group, though the female relative excess decreased from 75% higher in the 45-54-year-old age group to 33% higher in the 65-74-year-old age group (trend p-value=0.018). CONCLUSIONS: The relative gender difference in the impact of diabetes on IHD in younger middle-aged patients remained up to the age of 65 years, decreasing considerably thereafter.
OBJECTIVE: To explore age and gender differences in the impact of diabetes on the prevalence of ischemic heart disease (IHD) in a defined population. METHODS: Data were obtained from an administrative health care register covering a population of about 415,000. The study included all patients aged 45-74 years diagnosed between 1999 and 2003 with IHD (n=11,311) and diabetes (n=10,364) by physicians at all primary health care centres (PHCs) and out- and inpatient clinics at all hospitals in the county of Ostergötland, Sweden. RESULTS: In the 45-54-year-old age group, diabetes was associated with an increase in IHD prevalence equivalent to ageing about 20 years in women and 10 years in men. The diabetes/nondiabetes IHD prevalence rate ratio (IPR) decreased with age in both men and women (trend p-values <0.001). The IPR was higher among women than men in each age group, though the female relative excess decreased from 75% higher in the 45-54-year-old age group to 33% higher in the 65-74-year-old age group (trend p-value=0.018). CONCLUSIONS: The relative gender difference in the impact of diabetes on IHD in younger middle-aged patients remained up to the age of 65 years, decreasing considerably thereafter.
Authors: Pieter H van Baal; Peter M Engelfriet; Hendriek C Boshuizen; Jan van de Kassteele; Francois G Schellevis; Rudolf T Hoogenveen Journal: Popul Health Metr Date: 2011-09-01
Authors: Kristine Thorell; Jessica Skoog; Andrzej Zielinski; Lars Borgquist; Anders Halling Journal: BMC Public Health Date: 2012-07-31 Impact factor: 3.295